Article
Bridging Borders: IQVIA's Expertise in Global Clinical Trial Management
Unlocking global clinical trials with IQVIA FSP Country in a Box: strategies for seamless expansion
Jul 10, 2025
Download
Expanding Clinical Trials Globally? Here's What Pharma Leaders Need to Know

If you're a pharma leader planning to expand clinical trials into new countries, IQVIA's latest article—based on insights from our "Bridging Borders" webinar—is essential reading.

Global expansion offers more than just access to new patient populations. It's a strategic move to improve recruitment, reduce costs, and navigate regulatory flexibility. But success depends on more than ambition—it requires precision.

IQVIA's FSP Country in a Box solution is designed to simplify this complexity. It helps you identify the right countries using a data-driven "Country Readiness" score, factoring in infrastructure, patient availability, and regulatory environment. This ensures your expansion strategy is both feasible and future-proof.

The article also explores practical considerations: from understanding local data privacy laws (like GDPR and HIPAA) to managing logistics, language barriers, and financial contracting. It highlights often-overlooked requirements—like CRO licences or local residency for CRAs—that can delay trial start-up if missed.

A real-world case study shows how IQVIA helped a client enter a new region with no prior presence, using a two-stage approach that included readiness assessments, site feasibility, and tailored FSP teams.

For country managers and clinical leaders, this article is a roadmap to smarter, faster trial expansion. It's not just about going global—it's about doing it right.

Ready to expand your clinical trials with confidence? Contact IQVIA to learn how our tailored solutions can support your global strategy.

Related solutions

Contact Us